Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/07/21 → 7/07/26 |
Keywords
- treatment safety
- treatment efficacy
- prostate cancer
- Randomised clinical trial
Clinical Trial Phase
- Phase II
ENZA-p: A randomised phase II trial using PSMA as a therapeutic agent and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901)
- Pook, David (Primary Chief Investigator (PCI))
Project: Research